On an annual basis, revenue of KRW 310.6bn with operating profit of KRW 53.6bn (17.3% margin) in 2022 contracted sharply to KRW 276.5bn and KRW 24.3bn (8.8%) in 2023, recovered to KRW 338.1bn and KRW 61.2bn (18.1%) in 2024, and then registered KRW 350.3bn and KRW 51.7bn (14.7%) in 2025.
In other words, 2025 combined higher revenue with lower operating profit, consistent with a shift in tool mix alongside rising fixed costs such as R&D and labor.
The quarterly series shows even greater amplitude: from KRW 104.9bn revenue and KRW 19.7bn operating profit (18.8%) in the second quarter of 2025 down to KRW 62.3bn and KRW 5.2bn (8.3%) in the third, then back to KRW 99.9bn and KRW 17.5bn (17.6%) in the fourth and KRW 101.9bn and KRW 18.8bn (18.5%) in the first quarter of 2026.
The second quarter of 2026 delivered the highest revenue in the period shown at KRW 122.1bn, yet operating profit slipped slightly to KRW 18.2bn (14.9%), showing that top-line growth did not translate directly into margin expansion.
Summing the four quarters from the third quarter of 2025 through the second quarter of 2026 gives roughly KRW 386.2bn of revenue and KRW 59.7bn of operating profit, above the 2025 full-year totals.
Notably, second-quarter 2026 net profit attributable to owners of KRW 65.2bn far exceeded that quarter's KRW 18.2bn operating profit, implying a large non-operating contribution whose repeatability requires separate verification.
DB Financial Investment noted in a May 2026 report that first-quarter revenue and operating profit beat consensus by 5% and 20% respectively, driven by increased LPCVD and related tool shipments as DRAM customers pursued node conversion and capacity additions.
The balance sheet showed equity of KRW 491.4bn against liabilities of KRW 89.2bn at end-2025, a debt-to-equity ratio of 18.2%, while operating cash flow of KRW 66.5bn exceeded 2024's KRW 61.5bn, keeping cash conversion intact.